Cash flow Kumagai Gumi Co.,Ltd.

Stocks

1861

JP3266800006

Construction & Engineering

Market Closed - Japan Exchange Other stock markets 12:00:00 10/07/2026 pm IST			5-day change	1st Jan Change
1,484.00 ^JPY	-0.27%		+2.70%	-3.95%

15/05	Kumagai Gumi Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
15/05	Kumagai Gumi Co.,Ltd. Provides Dividend Guidance for the Second Quarter-End of Fiscal Year Ending March 31, 2027	CI

fbb03911d5b81c.rWJN5cdhz3ZOzUCGEUOzHdnEgQtPAFAgohiwZ0Z9bWk.lTAspJBRiRl6lAjwIDfKcqu07F15Whlok1TZSjVLJwPvJhnQ_yWOA3ysGQ

Published financial data: KUMAGAI GUMI CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	43TCr	40TCr	44TCr	50TCr	49TCr
Total Revenues	43TCr	40TCr	44TCr	50TCr	49TCr
Cost of Goods Sold, Total	38TCr	37TCr	41TCr	46TCr	43TCr
Gross Profit	4.35TCr	3.32TCr	3.61TCr	3.83TCr	5.32TCr
Selling General & Admin Expenses, Total	1.82TCr	1.92TCr	2.06TCr	2.1TCr	2.3TCr
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	248.8Cr	257.4Cr	285.2Cr	299.5Cr	318.2Cr
Other Operating Expenses, Total	2.07TCr	2.17TCr	2.34TCr	2.4TCr	2.61TCr
Operating Income	2.27TCr	1.15TCr	1.27TCr	1.43TCr	2.71TCr
Interest Expense, Total	-17Cr	-21Cr	-38Cr	-57Cr	-100Cr
Interest And Investment Income	60Cr	85Cr	94Cr	120.5Cr	145Cr
Net Interest Expenses	42Cr	64Cr	56Cr	63Cr	45Cr
Income (Loss) On Equity Invest.	24Cr	15Cr	17Cr	16Cr	-4.9Cr
Currency Exchange Gains (Loss)	17Cr	16Cr	11Cr	-2.8Cr	18Cr
Other Non Operating Income (Expenses)	15Cr	-19Cr	-45Cr	-65Cr	-63Cr
EBT, Excl. Unusual Items	2.37TCr	1.22TCr	1.3TCr	1.44TCr	2.7TCr
Gain (Loss) On Sale Of Investments	-	-	-4.6Cr	-28Cr	420.9Cr
Gain (Loss) On Sale Of Assets	6.8Cr	8.3Cr	90L	30L	4.1Cr
Asset Writedown	-15Cr	-4.2Cr	-1.7Cr	-1.2Cr	-81Cr
Legal Settlements	-48Cr	-10Cr	-31Cr	-29Cr	-50Cr
Other Unusual Items	-24Cr	-14Cr	-8.3Cr	-2.6Cr	-5.7Cr
EBT, Incl. Unusual Items	2.29TCr	1.2TCr	1.26TCr	1.38TCr	2.99TCr
Income Tax Expense	706.9Cr	405.7Cr	427.9Cr	444.5Cr	986.8Cr
Earnings From Continuing Operations	1.58TCr	797.3Cr	831.6Cr	935.4Cr	2.01TCr
Net Income to Company	1.58TCr	797.3Cr	831.6Cr	935.4Cr	2.01TCr
Minority Interest	-	-	-	-	20L
Net Income - (IS)	1.58TCr	797.3Cr	831.6Cr	935.4Cr	2.01TCr
Net Income to Common Incl Extra Items	1.58TCr	797.3Cr	831.6Cr	935.4Cr	2.01TCr
Net Income to Common Excl. Extra Items	1.58TCr	797.3Cr	831.6Cr	935.4Cr	2.01TCr
Per Share Items
Net EPS - Basic	85.53	44.91	48.09	54.43	116.94
Basic EPS - Continuing Operations	85.53	44.91	48.09	54.43	116.94
Basic Weighted Average Shares Outstanding	19Cr	18Cr	17Cr	17Cr	17Cr
Net EPS - Diluted	85.53	44.91	48.09	54.43	116.94
Diluted EPS - Continuing Operations	85.53	44.91	48.09	54.43	116.94
Diluted Weighted Average Shares Outstanding	19Cr	18Cr	17Cr	17Cr	17Cr
Normalized Basic EPS	80.04	43.07	47.13	52.41	98.52
Normalized Diluted EPS	80.04	43.07	47.13	52.41	98.52
Dividend Per Share	30	32.5	32.5	32.5	-
Payout Ratio	35.32	68.1	68.51	60.02	45.16
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.48TCr	1.34TCr	1.47TCr	1.64TCr	2.92TCr
EBITA	2.27TCr	1.15TCr	1.27TCr	1.43TCr	2.71TCr
EBIT	2.27TCr	1.15TCr	1.27TCr	1.43TCr	2.71TCr
Effective Tax Rate - (Ratio)	30.84	33.72	33.97	32.21	32.97
Normalized Net Income	1.48TCr	764.69Cr	814.94Cr	900.62Cr	1.69TCr
Non-Cash Pension Expense	34Cr	20Cr	19Cr	17Cr	60Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	272.5Cr	281.2Cr	314.8Cr	313.7Cr	341.8Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	6.74TCr	4.1TCr	7.01TCr	5.02TCr	6.47TCr
Total Cash And Short Term Investments	6.74TCr	4.1TCr	7.01TCr	5.02TCr	6.47TCr
Accounts Receivable, Total	20TCr	23TCr	27TCr	26TCr	24TCr
Other Receivables	1.7TCr	1.92TCr	2.21TCr	3.21TCr	2.24TCr
Total Receivables	22TCr	24TCr	29TCr	30TCr	26TCr
Inventory	1.02TCr	1.04TCr	846Cr	725.5Cr	769.2Cr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	251.5Cr	229.6Cr	233.3Cr	350.4Cr	261.2Cr
Total Current Assets	30TCr	30TCr	37TCr	36TCr	34TCr
Net Property Plant And Equipment	2.75TCr	2.93TCr	2.98TCr	3.25TCr	3.73TCr
Long-term Investments	3.26TCr	4.04TCr	5.6TCr	5.81TCr	5.92TCr
Other Intangibles, Total	88Cr	147.8Cr	159.2Cr	172.5Cr	201.2Cr
Loans Receivable Long-Term	27Cr	30Cr	686Cr	932.4Cr	846Cr
Deferred Tax Assets Long-Term	802.1Cr	691.4Cr	354.7Cr	348.8Cr	402.4Cr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	20L	10L	10L	10L	10L
Total Assets	37TCr	38TCr	47TCr	46TCr	45TCr
Liabilities
Accounts Payable, Total	11TCr	11TCr	13TCr	15TCr	11TCr
Accrued Expenses, Total	458.8Cr	405.7Cr	409.7Cr	414.4Cr	461.8Cr
Short-term Borrowings	314.5Cr	389.3Cr	2.59TCr	810.9Cr	1.16TCr
Current Income Taxes Payable	433Cr	77Cr	343.9Cr	137.2Cr	837.2Cr
Unearned Revenue Current, Total	1.29TCr	1.28TCr	2.31TCr	2.28TCr	1.81TCr
Other Current Liabilities	3.94TCr	3.9TCr	5.73TCr	4.72TCr	5.64TCr
Total Current Liabilities	18TCr	17TCr	24TCr	23TCr	21TCr
Long-Term Debt	900.7Cr	1.83TCr	2.65TCr	3.4TCr	3.82TCr
Pension & Other Post Retirement Benefits	1.66TCr	1.67TCr	1.64TCr	1.63TCr	1.41TCr
Deferred Tax Liability Non Current	-	-	-	7.3Cr	2.3Cr
Other Non Current Liabilities	77Cr	85Cr	85Cr	89Cr	107.6Cr
Total Liabilities	20TCr	21TCr	29TCr	28TCr	26TCr
Common Stock, Total	3.01TCr	3.01TCr	3.01TCr	3.01TCr	3.01TCr
Additional Paid In Capital	2.11TCr	1.71TCr	1.52TCr	1.52TCr	1.52TCr
Retained Earnings	11TCr	12TCr	12TCr	12TCr	13TCr
Treasury Stock	-63Cr	-63Cr	-66Cr	-99Cr	-437.7Cr
Comprehensive Income and Other	371.2Cr	574.7Cr	1.53TCr	1.37TCr	1.25TCr
Total Common Equity	17TCr	17TCr	18TCr	18TCr	19TCr
Total Equity	17TCr	17TCr	18TCr	18TCr	19TCr
Total Liabilities And Equity	37TCr	38TCr	47TCr	46TCr	45TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18Cr	17Cr	17Cr	17Cr	17Cr
ECS Total Common Shares Outstanding	18Cr	17Cr	17Cr	17Cr	-
Book Value / Share	937.76	973.52	1.05T	1.06T	1.11T
Tangible Book Value	17TCr	17TCr	18TCr	18TCr	19TCr
Tangible Book Value Per Share	932.91	965.05	1.04T	1.05T	1.09T
Total Debt	1.22TCr	2.22TCr	5.24TCr	4.21TCr	4.97TCr
Net Debt	-5.53TCr	-1.88TCr	-1.77TCr	-802.1Cr	-1.49TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.66TCr	1.67TCr	1.64TCr	1.63TCr	1.41TCr
Inventories - Work In Process, Total	1.02TCr	1.04TCr	846Cr	725.5Cr	769.2Cr
Full Time Employees	4.34T	4.41T	4.43T	4.54T	4.51T
Accumulated Allowance for Doubtful Accounts (Supple)	4.8Cr	5.6Cr	6.4Cr	6.5Cr	6.7Cr
Order Backlog	49TCr	53TCr	58TCr	59TCr	-

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	2.29TCr	1.2TCr	1.26TCr	1.38TCr	2.99TCr
Depreciation & Amortization - CF	202.8Cr	189.8Cr	206.2Cr	206.8Cr	213.6Cr
Depreciation & Amortization, Total	202.8Cr	189.8Cr	206.2Cr	206.8Cr	213.6Cr
(Gain) Loss From Sale Of Asset	2.8Cr	3.6Cr	80L	90L	77Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	28Cr	-420.3Cr
(Income) Loss On Equity Investments - (CF)	-24Cr	-15Cr	-17Cr	-16Cr	4.9Cr
Other Operating Activities, Total	-680.9Cr	-787.1Cr	-161.4Cr	-576.2Cr	-302.5Cr
Change In Accounts Receivable	-730.5Cr	-2.04TCr	-4.05TCr	260.8Cr	2.45TCr
Change In Inventories	-371.4Cr	-21Cr	201.5Cr	122.2Cr	-42Cr
Change In Accounts Payable	-1.23TCr	-209.2Cr	1.74TCr	1.51TCr	-3.76TCr
Change in Other Net Operating Assets	1.36TCr	-205.4Cr	2.51TCr	-2.09TCr	1.29TCr
Cash from Operations	825.8Cr	-1.88TCr	1.7TCr	823.3Cr	2.5TCr
Capital Expenditure	-315.8Cr	-434.3Cr	-223.9Cr	-407.4Cr	-468.3Cr
Sale of Property, Plant, and Equipment	5.6Cr	20Cr	90L	40L	18Cr
Cash Acquisitions	-12Cr	-328.5Cr	-157.3Cr	-384.3Cr	-465.4Cr
Divestitures	-	-	-	-	690.3Cr
Investment in Marketable and Equity Securities, Total	-1.9Cr	-36Cr	-2.6Cr	-98Cr	-164.5Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	38Cr	-1.5Cr	-654.5Cr	-262.5Cr	-189.2Cr
Other Investing Activities, Total	-53Cr	-66Cr	-40Cr	-47Cr	-67Cr
Cash from Investing	-339.5Cr	-845.8Cr	-1.08TCr	-1.2TCr	-645.8Cr
Short Term Debt Issued, Total	-	30Cr	4.71TCr	21TCr	-
Long-Term Debt Issued, Total	168.5Cr	1.02TCr	1.4TCr	907Cr	1.25TCr
Total Debt Issued	168.5Cr	1.04TCr	6.11TCr	22TCr	1.25TCr
Short Term Debt Repaid, Total	-28Cr	-	-3TCr	-22TCr	-355.9Cr
Long-Term Debt Repaid, Total	-114.6Cr	-40Cr	-91Cr	-580.4Cr	-145.9Cr
Total Debt Repaid	-142.1Cr	-40Cr	-3.09TCr	-23TCr	-501.8Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-421.2Cr	-401.2Cr	-202.5Cr	-43Cr	-351.4Cr
Common Dividends Paid	-559.8Cr	-543Cr	-569.7Cr	-561.4Cr	-906.2Cr
Common & Preferred Stock Dividends Paid	-559.8Cr	-543Cr	-569.7Cr	-561.4Cr	-906.2Cr
Other Financing Activities, Total	-14Cr	-15Cr	-13Cr	-12Cr	-13Cr
Cash from Financing	-968.6Cr	46Cr	2.23TCr	-1.65TCr	-526.8Cr
Foreign Exchange Rate Adjustments	89Cr	40Cr	59Cr	31Cr	52Cr
Miscellaneous Cash Flow Adjustments	10L	-	10L	10L	71Cr
Net Change in Cash	-393.1Cr	-2.64TCr	2.91TCr	-1.99TCr	1.45TCr
Supplemental Items
Cash Interest Paid	18Cr	21Cr	38Cr	57Cr	93Cr
Cash Income Tax Paid (Refund)	683.8Cr	787.1Cr	159Cr	567Cr	301.3Cr
Levered Free Cash Flow	475.16Cr	-2.35TCr	1.59TCr	243.8Cr	2.27TCr
Unlevered Free Cash Flow	486.04Cr	-2.33TCr	1.62TCr	279.49Cr	2.33TCr
Change In Net Working Capital	822.4Cr	2.81TCr	-843.8Cr	413.6Cr	-889.3Cr
Net Debt Issued / Repaid	26Cr	1TCr	3.02TCr	-1.03TCr	743.9Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	3.79	1.92	1.87	1.92	3.72
Return on Total Capital	7.96	3.84	3.73	3.92	7.34
Return On Equity %	9.52	4.7	4.75	5.17	10.86
Return on Common Equity	9.52	4.7	4.75	5.17	10.86
Margin Analysis
Gross Profit Margin %	10.22	8.23	8.14	7.68	10.92
SG&A Margin	4.29	4.75	4.64	4.22	4.71
EBITDA Margin %	5.83	3.32	3.32	3.28	5.99
EBITA Margin %	5.35	2.85	2.85	2.87	5.56
EBIT Margin %	5.35	2.85	2.85	2.87	5.56
Income From Continuing Operations Margin %	3.73	1.98	1.88	1.88	4.11
Net Income Margin %	3.73	1.98	1.88	1.88	4.11
Net Avail. For Common Margin %	3.73	1.98	1.88	1.88	4.11
Normalized Net Income Margin	3.49	1.9	1.84	1.81	3.47
Levered Free Cash Flow Margin	1.12	-5.81	3.59	0.49	4.65
Unlevered Free Cash Flow Margin	1.14	-5.78	3.65	0.56	4.77
Asset Turnover
Asset Turnover	1.13	1.08	1.05	1.07	1.07
Fixed Assets Turnover	16.01	14.22	15	16.01	13.99
Receivables Turnover (Average Receivables)	2.12	1.88	1.8	1.88	1.93
Inventory Turnover (Average Inventory)	45.83	35.88	43.09	58.58	58.13
Short Term Liquidity
Current Ratio	1.72	1.75	1.52	1.56	1.63
Quick Ratio	1.65	1.67	1.47	1.51	1.58
Operating Cash Flow to Current Liabilities	0.05	-0.11	0.07	0.04	0.12
Days Sales Outstanding (Average Receivables)	172.41	194.56	203.1	194.32	188.93
Days Outstanding Inventory (Average Inventory)	7.96	10.17	8.49	6.23	6.28
Average Days Payable Outstanding	110.35	109.1	108.44	109.48	106.73
Cash Conversion Cycle (Average Days)	70.03	95.63	103.16	91.07	88.48
Long Term Solvency
Total Debt/Equity	7.18	13.07	29.1	23.17	26.47
Total Debt / Total Capital	6.7	11.56	22.54	18.81	20.93
LT Debt/Equity	5.32	10.78	14.71	18.71	20.31
Long-Term Debt / Total Capital	4.96	9.53	11.39	15.19	16.06
Total Liabilities / Total Assets	54.38	54.9	61.47	60.69	58.15
EBIT / Interest Expense	130.71	55.21	33.38	25.04	27.15
EBITDA / Interest Expense	142.36	64.33	38.82	28.66	29.29
(EBITDA - Capex) / Interest Expense	124.21	43.45	32.91	21.53	24.6
Total Debt / EBITDA	0.49	1.66	3.56	2.57	1.7
Net Debt / EBITDA	-2.23	-1.4	-1.2	-0.49	-0.51
Total Debt / (EBITDA - Capex)	0.56	2.46	4.2	3.43	2.03
Net Debt / (EBITDA - Capex)	-2.56	-2.08	-1.42	-0.65	-0.61
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.56	-5.11	9.84	12.5	-2.18
Gross Profit, 1 Yr. Growth %	-9.61	-23.59	8.64	6.19	38.95
EBITDA, 1 Yr. Growth %	-17.79	-45.98	9.95	11.24	78.58
EBITA, 1 Yr. Growth %	-18.98	-49.51	10.17	13.03	89.47
EBIT, 1 Yr. Growth %	-18.98	-49.51	10.17	13.03	89.47
Earnings From Cont. Operations, 1 Yr. Growth %	-11.58	-49.7	4.3	12.48	114.52
Net Income, 1 Yr. Growth %	-11.58	-49.7	4.3	12.48	114.54
Normalized Net Income, 1 Yr. Growth %	-16.44	-48.45	6.57	10.51	87.73
Diluted EPS Before Extra, 1 Yr. Growth %	-11.06	-47.5	7.08	13.18	114.84
Accounts Receivable, 1 Yr. Growth %	3.97	10.08	18.23	-0.79	-9.03
Inventory, 1 Yr. Growth %	58.12	2.27	-18.94	-14.24	6.02
Net Property, Plant and Equip., 1 Yr. Growth %	6.99	6.77	1.69	8.96	14.74
Total Assets, 1 Yr. Growth %	-2.23	1.5	24.05	-1.01	-2.94
Tangible Book Value, 1 Yr. Growth %	3.15	-0.03	5.96	0.94	3.19
Common Equity, 1 Yr. Growth %	3.34	0.33	5.98	1.01	3.32
Cash From Operations, 1 Yr. Growth %	25.65	-327.97	-190.15	-51.49	203.85
Capital Expenditures, 1 Yr. Growth %	50.81	37.52	-48.45	81.96	14.95
Levered Free Cash Flow, 1 Yr. Growth %	240.13	-593.56	-167.93	-84.7	829.26
Unlevered Free Cash Flow, 1 Yr. Growth %	220.66	-579.84	-169.32	-82.71	732.92
Dividend Per Share, 1 Yr. Growth %	0	8.33	0	0	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.26	-5.33	2.09	11.16	4.9
Gross Profit, 2 Yr. CAGR %	-2.26	-16.89	-8.89	7.41	21.47
EBITDA, 2 Yr. CAGR %	-5.21	-33.36	-22.93	10.6	40.95
EBITA, 2 Yr. CAGR %	-5.45	-36.04	-25.42	11.59	46.34
EBIT, 2 Yr. CAGR %	-5.45	-36.04	-25.42	11.59	46.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.72	-33.31	-27.57	8.31	55.34
Net Income, 2 Yr. CAGR %	-9.72	-33.31	-27.57	8.31	55.34
Normalized Net Income, 2 Yr. CAGR %	-3.94	-34.36	-25.88	8.52	44.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-9.46	-31.67	-25.02	10.09	55.94
Accounts Receivable, 2 Yr. CAGR %	3.7	6.98	14.08	8.3	-5
Inventory, 2 Yr. CAGR %	13.92	27.17	-8.95	-16.63	-4.65
Net Property, Plant and Equip., 2 Yr. CAGR %	4.07	6.88	4.2	5.26	11.81
Total Assets, 2 Yr. CAGR %	-0.5	-0.39	12.21	10.82	-1.98
Tangible Book Value, 2 Yr. CAGR %	6.86	1.55	2.92	3.42	2.06
Common Equity, 2 Yr. CAGR %	6.94	1.82	3.12	3.46	2.16
Cash From Operations, 2 Yr. CAGR %	389.25	69.25	43.36	-33.87	21.41
Capital Expenditures, 2 Yr. CAGR %	19.84	44.01	-15.8	-3.15	44.62
Levered Free Cash Flow, 2 Yr. CAGR %	-1.49	309.73	83.11	-67.76	19.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.84	292.26	82.39	-65.38	19.99
Dividend Per Share, 2 Yr. CAGR %	0	4.08	4.08	0	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.01	-2.56	-0.52	5.45	6.52
Gross Profit, 3 Yr. CAGR %	-1.54	-9.96	-9.13	-4.12	17.04
EBITDA, 3 Yr. CAGR %	-4.51	-21.41	-21.25	-12.9	29.75
EBITA, 3 Yr. CAGR %	-4.93	-23.29	-23.33	-14.33	33.13
EBIT, 3 Yr. CAGR %	-4.93	-23.29	-23.33	-14.33	33.13
Earnings From Cont. Operations, 3 Yr. CAGR %	5.99	-25.71	-22.59	-16.12	36.02
Net Income, 3 Yr. CAGR %	5.99	-25.71	-22.59	-16.12	36.03
Normalized Net Income, 3 Yr. CAGR %	-3.67	-21.93	-22.85	-15.32	30.28
Diluted EPS Before Extra, 3 Yr. CAGR %	6.22	-24.5	-20.63	-13.99	37.58
Accounts Receivable, 3 Yr. CAGR %	5.27	5.78	10.6	8.89	2.19
Inventory, 3 Yr. CAGR %	11.81	9.89	9.44	-10.75	-9.67
Net Property, Plant and Equip., 3 Yr. CAGR %	3.39	4.96	5.12	5.76	8.33
Total Assets, 3 Yr. CAGR %	1.61	0.16	7.17	7.62	6.03
Tangible Book Value, 3 Yr. CAGR %	7.81	4.51	3	2.26	3.35
Common Equity, 3 Yr. CAGR %	7.87	4.69	3.19	2.41	3.42
Cash From Operations, 3 Yr. CAGR %	-12.67	279.3	37.19	-0.1	9.94
Capital Expenditures, 3 Yr. CAGR %	-24.18	25.46	2.26	8.86	2.54
Levered Free Cash Flow, 3 Yr. CAGR %	-17.48	68.56	125.09	-19.94	-1.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	-16.38	69.62	120.13	-16.84	-0.06
Dividend Per Share, 3 Yr. CAGR %	6.27	2.7	2.7	2.7	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.29	1.53	2.64	2.71	1.61
Gross Profit, 5 Yr. CAGR %	1.14	-3.76	-4.55	-3.38	2.06
EBITDA, 5 Yr. CAGR %	-1.42	-11.61	-12.36	-9.9	-0.61
EBITA, 5 Yr. CAGR %	-2.06	-13.01	-13.72	-10.88	-0.71
EBIT, 5 Yr. CAGR %	-2.06	-13.01	-13.72	-10.88	-0.71
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.72	-12.77	-8.98	-13.62	2.28
Net Income, 5 Yr. CAGR %	-0.72	-12.77	-8.98	-13.62	2.28
Normalized Net Income, 5 Yr. CAGR %	-1.32	-11.61	-13.26	-10.94	-0.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.9	-14.35	-7.59	-12.2	3.99
Accounts Receivable, 5 Yr. CAGR %	10.5	10.13	8.71	6.78	4.08
Inventory, 5 Yr. CAGR %	7.48	8.61	2.99	-1.6	3.57
Net Property, Plant and Equip., 5 Yr. CAGR %	9.8	8.49	3.71	5.08	7.75
Total Assets, 5 Yr. CAGR %	6.42	2.45	5.72	4.29	3.41
Tangible Book Value, 5 Yr. CAGR %	16.1	5.98	5.83	4.08	2.62
Common Equity, 5 Yr. CAGR %	16.09	6.09	5.94	4.2	2.78
Cash From Operations, 5 Yr. CAGR %	-0.87	1.31	6.48	88.6	30.65
Capital Expenditures, 5 Yr. CAGR %	1.13	2.91	-20.93	13.13	17.47
Levered Free Cash Flow, 5 Yr. CAGR %	-1.37	9.12	13.5	-13.02	74.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.61	8.78	14.23	-10.17	72.69
Dividend Per Share, 5 Yr. CAGR %	11.38	13.18	5.39	1.61	-